Christoph Steeneck

City:

Dossenheim

Country:

Germany

Published Applications:

Last publication date:

2019-05-16

Top Assignees for applications by Christoph Steeneck

The entities that hold a legal rights for patent applications filed by inventor Steeneck Christoph:

PHENEX PHARMACEUTICALS AG 7 Ludwigshafen, Germany
Gilead Sciences, Inc. 5 Foster City, CA United States
Alantos Pharmaceuticals Holding, Inc. 3 Cambridge, MA United States
Alantos Pharmaceuticals Holding, Inc. 3 Thousand Oaks, CA United States
Amgen Inc. 2 Thousand Oaks, CA United States
Atlantos Pharmaceuticals Holding, Inc. 1 Thousand Oaks, CA United States

Recent patent applications by Steeneck Christoph

Christoph Steeneck from Dossenheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-05-16

US20190142814A1

Human necessities

FXR (NR1H4) binding and activity modulating compounds

#2 | 2018-07-19

US20180200243A1

Human necessities

FXR (NR1H4) binding and activity modulating compounds

#3 | 2017-05-25

US20170143684A1

Human necessities

FXR (NR1H4) binding and activity modulating compounds

#4 | 2015-12-03

US20150344423A1

Chemistry; metallurgy

Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ

#5 | 2015-12-03

US20150342930A1

Human necessities

FXR (NR1H4) binding and activity modulating compounds

#6 | 2015-06-25

US20150175562A1

Chemistry; metallurgy

Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]

#7 | 2014-11-27

US20140349987A1

Chemistry; metallurgy

Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases

#8 | 2014-08-07

US20140221659A1

Chemistry; metallurgy

FXR (NR1H4) binding and activity modulating compounds

#9 | 2014-05-22

US20140142082A1

Chemistry; metallurgy

Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases

#10 | 2013-02-28

US20130053380A1

Chemistry; metallurgy

Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease

#11 | 2012-09-13